These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 8082711)

  • 1. K+ channel activators, acute glucose tolerance and glibenclamide-induced hypoglycaemia in the hypertensive rat.
    Clapham JC; Trail BK; Hamilton TC
    Eur J Pharmacol; 1994 May; 257(1-2):79-85. PubMed ID: 8082711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of diazoxide, cromakalim and pinacidil on adrenergic neurotransmission and 86Rb+ efflux in rat brain cortical slices.
    Takata Y; Shimada F; Kato H
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1293-301. PubMed ID: 1469635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition by sulphonylureas of vasorelaxation induced by K+ channel activators in vitro.
    Wilson C
    J Auton Pharmacol; 1989 Feb; 9(1):71-8. PubMed ID: 2498342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-ischemic effects of the potassium channel activators pinacidil and cromakalim and the reversal of these effects with the potassium channel blocker glyburide.
    Grover GJ; McCullough JR; Henry DE; Conder ML; Sleph PG
    J Pharmacol Exp Ther; 1989 Oct; 251(1):98-104. PubMed ID: 2507775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of several potassium channel openers and glibenclamide on the uterus of the rat.
    Piper I; Minshall E; Downing SJ; Hollingsworth M; Sadraei H
    Br J Pharmacol; 1990 Dec; 101(4):901-7. PubMed ID: 2128195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the K+ channel activators, RP 52891, cromakalim and diazoxide, on the plasma insulin level, plasma renin activity and blood pressure in rats.
    Pratz J; Mondot S; Montier F; Cavero I
    J Pharmacol Exp Ther; 1991 Jul; 258(1):216-22. PubMed ID: 1906538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo comparison of two K+ channel openers, diazoxide and cromakalim, and their inhibition by glibenclamide.
    Quast U; Cook NS
    J Pharmacol Exp Ther; 1989 Jul; 250(1):261-71. PubMed ID: 2501478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of putative activators of K+ channels in mouse pancreatic beta-cells.
    Garrino MG; Plant TD; Henquin JC
    Br J Pharmacol; 1989 Nov; 98(3):957-65. PubMed ID: 2531623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired action of levcromakalim on ATP-sensitive K+ channels in mesenteric artery cells from spontaneously hypertensive rats.
    Ohya Y; Setoguchi M; Fujii K; Nagao T; Abe I; Fujishima M
    Hypertension; 1996 Jun; 27(6):1234-9. PubMed ID: 8641729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular effects of the novel potassium channel opener UR-8225.
    Tamargo J; Pérez O; Delpón E; García-Rafanell J; Gómez L; Cavalcanti F
    J Cardiovasc Pharmacol; 1995 Aug; 26(2):295-305. PubMed ID: 7475055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cromakalim, pinacidil and glibenclamide on cholinergic transmission in rat isolated atria.
    Fabiani ME; Story DF
    Pharmacol Res; 1995 Sep; 32(3):155-63. PubMed ID: 8745346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KATP channel modulators increase survival rate during coronary occlusion-reperfusion in anaesthetized rats.
    Baczkó I; Leprán I; Papp JG
    Eur J Pharmacol; 1997 Apr; 324(1):77-83. PubMed ID: 9137916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of potassium on the action of the KATP modulators cromakalim, pinacidil, or glibenclamide on arrhythmias in isolated perfused rat heart subjected to regional ischaemia.
    D'Alonzo AJ; Darbenzio RB; Hess TA; Sewter JC; Sleph PG; Grover GJ
    Cardiovasc Res; 1994 Jun; 28(6):881-7. PubMed ID: 7923295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of levcromakalim and pinacidil on the human internal mammary artery.
    Gojkoviíc Bukarica L; Kazić T; Sajić Z; Djukanović B; Panić G; Perić M; Bojić M
    Fundam Clin Pharmacol; 1997; 11(6):550-60. PubMed ID: 9444523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of potassium channel blockers on the negative inotropic responses induced by cromakalim and pinacidil in guinea pig atrium.
    Lau WM
    Pharmacology; 1992; 45(1):9-16. PubMed ID: 1508969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATP-sensitive potassium channels in isolated rat aorta during physiologic, hypoxic, and low-glucose conditions.
    Hüsken BC; Pfaffendorf M; van Zwieten PA
    J Cardiovasc Pharmacol; 1997 Jan; 29(1):130-5. PubMed ID: 9007682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and properties of an ATP-sensitive K+ current in rabbit sino-atrial node pacemaker cells.
    Han X; Light PE; Giles WR; French RJ
    J Physiol; 1996 Jan; 490 ( Pt 2)(Pt 2):337-50. PubMed ID: 8821133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of responses to cromakalim and pinacidil in smooth and cardiac muscle by use of selective antagonists.
    McPherson GA; Angus JA
    Br J Pharmacol; 1990 Jun; 100(2):201-6. PubMed ID: 2116201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of endothelin-1 on the vasorelaxant properties of benzopyran and non-benzopyran potassium channel openers.
    Lawson K; Barras M; Zazzi-Sudriez E; Martin DJ; Armstrong JM; Hicks PE
    Br J Pharmacol; 1992 Sep; 107(1):58-65. PubMed ID: 1422579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of rabbit aortic Ca(2+)-activated K+ channels by pinacidil, cromakalim, and glibenclamide.
    Gelband GH; McCullough JR
    Am J Physiol; 1993 May; 264(5 Pt 1):C1119-27. PubMed ID: 8498475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.